跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUKAKLINE CHEWABLE TABLET 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
LUKAKLINE CHEWABLE TABLET 5MG
Approved
THERAPEUTIC
LUKAKLINE CHEWABLE TABLET 5MG
DR. REDDY'S LABORATORIES LIMITED FTO-III (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Mar 21, 2013
Approval ID
95fbd8ef96c4c7ab
Company
DR. REDDY'S LABORATORIES LIMITED FTO-III (INDIA)
Type
Therapeutic
Approval Details
Approval Id
95fbd8ef96c4c7ab
Drug Name
LUKAKLINE CHEWABLE TABLET 5MG
Product Name
LUKAKLINE CHEWABLE TABLET 5MG
Approval Number
SIN14331P
Approval Date
2013-03-21
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, CHEWABLE
Route Of Administration
ORAL
Atc Code
R03DC03
Atc Item Name
montelukast
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Montelukast sodium 5.2mg eqv. Montelukast
5 mg
MONTELUKAST SODIUM 5.2 MG EQV. MONTELUKAST
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 21, 2013
Approval ID
95fbd8ef96c4c7ab
Type
Therapeutic
Back to HSA Approvals